559 related articles for article (PubMed ID: 34709727)
41. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
Caruso A; Caccuri F; Bugatti A; Zani A; Vanoni M; Bonfanti P; Cazzaniga ME; Perno CF; Messa C; Alberghina L
J Med Virol; 2021 Mar; 93(3):1780-1785. PubMed ID: 32926453
[TBL] [Abstract][Full Text] [Related]
42. Perspectives for repurposing drugs for the coronavirus disease 2019.
Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
[TBL] [Abstract][Full Text] [Related]
43. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.
Sokullu E; Pinard M; Gauthier MS; Coulombe B
Expert Opin Drug Discov; 2021 Aug; 16(8):881-895. PubMed ID: 33769912
[No Abstract] [Full Text] [Related]
45. Human coronaviruses and therapeutic drug discovery.
Song LG; Xie QX; Lao HL; Lv ZY
Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
[TBL] [Abstract][Full Text] [Related]
46. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
Eskandarzade N; Ghorbani A; Samarfard S; Diaz J; Guzzi PH; Fariborzi N; Tahmasebi A; Izadpanah K
Comput Biol Med; 2022 Jul; 146():105575. PubMed ID: 35533462
[TBL] [Abstract][Full Text] [Related]
47. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
Chen N; Zhang B; Deng L; Liang B; Ping J
Emerg Microbes Infect; 2022 Dec; 11(1):1371-1389. PubMed ID: 35476817
[TBL] [Abstract][Full Text] [Related]
48. Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study.
Pirolli D; Righino B; De Rosa MC
Mol Inform; 2021 Jun; 40(6):e2060080. PubMed ID: 33904240
[TBL] [Abstract][Full Text] [Related]
49. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.
Klann K; Bojkova D; Tascher G; Ciesek S; Münch C; Cinatl J
Mol Cell; 2020 Oct; 80(1):164-174.e4. PubMed ID: 32877642
[TBL] [Abstract][Full Text] [Related]
50. Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.
Chan SW; Shafi T; Ford RC
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835112
[TBL] [Abstract][Full Text] [Related]
51. Drugs against SARS-CoV-2: What do we know about their mode of action?
Valle C; Martin B; Touret F; Shannon A; Canard B; Guillemot JC; Coutard B; Decroly E
Rev Med Virol; 2020 Nov; 30(6):1-10. PubMed ID: 32779326
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model.
Chen YT; Chang YH; Pathak N; Tzou SC; Luo YC; Hsu YC; Li TN; Lee JY; Chen YC; Huang YW; Yang HJ; Hsu NY; Tsai HP; Chang TY; Hsu SC; Liu PC; Chin YF; Lin WC; Yang CM; Wu HL; Lee CY; Hsu HL; Liu YC; Chu JW; Wang LH; Wang JY; Huang CH; Lin CH; Hsieh PS; Wu Lee YH; Hung YJ; Yang JM
Front Immunol; 2022; 13():1080897. PubMed ID: 36618412
[TBL] [Abstract][Full Text] [Related]
53. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
Coban MA; Morrison J; Maharjan S; Hernandez Medina DH; Li W; Zhang YS; Freeman WD; Radisky ES; Le Roch KG; Weisend CM; Ebihara H; Caulfield TR
Biomolecules; 2021 May; 11(6):. PubMed ID: 34071060
[TBL] [Abstract][Full Text] [Related]
54. Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
Boytz R; Słabicki M; Ramaswamy S; Patten JJ; Zou C; Meng C; Hurst BL; Wang J; Nowak RP; Yang PL; Sattler M; Stone RM; Griffin JD; Gray NS; Gummuluru S; Davey RA; Weisberg E
J Med Virol; 2023 Jan; 95(1):e28157. PubMed ID: 36117402
[TBL] [Abstract][Full Text] [Related]
55. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
56. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review.
Kumar S; Sarma P; Kaur H; Prajapat M; Bhattacharyya A; Avti P; Sehkhar N; Kaur H; Bansal S; Mahendiratta S; Mahalmani VM; Singh H; Prakash A; Kuhad A; Medhi B
Tissue Cell; 2021 Jun; 70():101497. PubMed ID: 33550034
[TBL] [Abstract][Full Text] [Related]
57. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
58. Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication.
Zhang Y; Tang LV
J Proteome Res; 2021 Jan; 20(1):49-59. PubMed ID: 33347311
[TBL] [Abstract][Full Text] [Related]
59. Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.
Czuppon P; Débarre F; Gonçalves A; Tenaillon O; Perelson AS; Guedj J; Blanquart F
PLoS Comput Biol; 2021 Mar; 17(3):e1008752. PubMed ID: 33647008
[TBL] [Abstract][Full Text] [Related]
60. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.
Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
